GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (LTS:0DHC) » Definitions » Cyclically Adjusted FCF per Share

Carl Zeiss Meditec AG (LTS:0DHC) Cyclically Adjusted FCF per Share : €2.10 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Carl Zeiss Meditec AG Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Carl Zeiss Meditec AG's adjusted free cash flow per share for the three months ended in Dec. 2023 was €0.011. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €2.10 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Carl Zeiss Meditec AG's average Cyclically Adjusted FCF Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Carl Zeiss Meditec AG was 31.80% per year. The lowest was 28.70% per year. And the median was 30.25% per year.

As of today (2024-04-28), Carl Zeiss Meditec AG's current stock price is €100.725. Carl Zeiss Meditec AG's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was €2.10. Carl Zeiss Meditec AG's Cyclically Adjusted Price-to-FCF of today is 47.96.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Carl Zeiss Meditec AG was 145.26. The lowest was 44.59. And the median was 99.95.


Carl Zeiss Meditec AG Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Carl Zeiss Meditec AG's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Cyclically Adjusted FCF per Share Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 1.04 1.66 1.97 -

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.95 2.01 - - 2.10

Competitive Comparison of Carl Zeiss Meditec AG's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Cyclically Adjusted Price-to-FCF falls into.



Carl Zeiss Meditec AG Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Carl Zeiss Meditec AG's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.011/123.6675*123.6675
=0.011

Current CPI (Dec. 2023) = 123.6675.

Carl Zeiss Meditec AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.305 99.543 0.379
201406 0.137 99.543 0.170
201409 0.215 99.823 0.266
201412 -0.166 99.543 -0.206
201503 0.100 99.717 0.124
201506 0.064 100.417 0.079
201509 0.493 100.417 0.607
201512 0.035 99.717 0.043
201603 0.363 100.017 0.449
201606 0.445 100.717 0.546
201609 0.183 101.017 0.224
201612 0.000 101.217 0.000
201703 0.000 101.417 0.000
201706 0.000 102.117 0.000
201709 0.000 102.717 0.000
201712 -0.019 102.617 -0.023
201803 0.405 102.917 0.487
201806 0.761 104.017 0.905
201809 0.937 104.718 1.107
201812 0.263 104.217 0.312
201903 0.736 104.217 0.873
201906 0.394 105.718 0.461
201909 1.061 106.018 1.238
201912 0.293 105.818 0.342
202003 0.160 105.718 0.187
202006 0.250 106.618 0.290
202009 1.309 105.818 1.530
202012 0.455 105.518 0.533
202103 1.251 107.518 1.439
202106 0.857 108.486 0.977
202109 1.505 109.435 1.701
202112 -0.165 110.384 -0.185
202203 0.995 113.968 1.080
202206 0.161 115.760 0.172
202209 1.107 118.818 1.152
202212 0.203 119.345 0.210
202303 0.329 122.402 0.332
202306 0.000 123.140 0.000
202309 0.000 124.195 0.000
202312 0.011 123.668 0.011

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Carl Zeiss Meditec AG  (LTS:0DHC) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Carl Zeiss Meditec AG's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=100.725/2.1
=47.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Carl Zeiss Meditec AG was 145.26. The lowest was 44.59. And the median was 99.95.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Carl Zeiss Meditec AG Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (LTS:0DHC) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (LTS:0DHC) Headlines

No Headlines